Dr Lal PathLabs a well recognised brand in the Diagnostic Sector

Q3 FY21 results are out and below is the investor presentation

I am surprised looking at the low level of interest in this thread. The company has eye for detail with respect to numbers. Their strategic goals and execution seems to be very good.

New areas

Robust tracking

Even though they are mentioning about robust/real-time tracking, the reviews are quite bad for Gurgaon centre. This is one con to look at.

Discl - Invested. Southern_Cross's Portfolio - #15 by Southern_Cross

11 Likes